(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 23.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.4%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.5%.
Rxsight's revenue in 2025 is $139,927,000.On average, 6 Wall Street analysts forecast RXST's revenue for 2025 to be $7,045,597,251, with the lowest RXST revenue forecast at $6,591,860,238, and the highest RXST revenue forecast at $7,770,539,915. On average, 6 Wall Street analysts forecast RXST's revenue for 2026 to be $8,595,656,180, with the lowest RXST revenue forecast at $7,750,699,550, and the highest RXST revenue forecast at $9,944,477,115.
In 2027, RXST is forecast to generate $10,184,181,124 in revenue, with the lowest revenue forecast at $8,631,773,744 and the highest revenue forecast at $12,406,302,069.